RxSight Inc. (RXST)
RxSight Statistics
Share Statistics
RxSight has 40.49M shares outstanding. The number of shares has increased by 8.97% in one year.
| Shares Outstanding | 40.49M |
| Shares Change (YoY) | 8.97% |
| Shares Change (QoQ) | 1.57% |
| Owned by Institutions (%) | 85.26% |
| Shares Floating | 38.3M |
| Failed to Deliver (FTD) Shares | 78 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.28M, so 5.66% of the outstanding shares have been sold short.
| Short Interest | 2.28M |
| Short % of Shares Out | 5.66% |
| Short % of Float | 5.96% |
| Short Ratio (days to cover) | 2.91 |
Valuation Ratios
The PE ratio is -48.67 and the forward PE ratio is 236.09. RxSight's PEG ratio is 0.98.
| PE Ratio | -48.67 |
| Forward PE | 236.09 |
| PS Ratio | 9.55 |
| Forward PS | 3.6 |
| PB Ratio | 4.75 |
| P/FCF Ratio | -59.69 |
| PEG Ratio | 0.98 |
Enterprise Valuation
RxSight Inc. has an Enterprise Value (EV) of 1.38B.
| EV / Earnings | -50.36 |
| EV / Sales | 9.88 |
| EV / EBITDA | -58.19 |
| EV / EBIT | -37.51 |
| EV / FCF | -61.76 |
Financial Position
The company has a current ratio of 11.36, with a Debt / Equity ratio of 0.04.
| Current Ratio | 11.36 |
| Quick Ratio | 10.5 |
| Debt / Equity | 0.04 |
| Total Debt / Capitalization | 4.19 |
| Cash Flow / Debt | -1.38 |
| Interest Coverage | -1755.14 |
Financial Efficiency
Return on equity (ROE) is -0.1% and return on capital (ROIC) is -12.58%.
| Return on Equity (ROE) | -0.1% |
| Return on Assets (ROA) | -0.09% |
| Return on Capital (ROIC) | -12.58% |
| Revenue Per Employee | $280,977.91 |
| Profits Per Employee | $-55,130.52 |
| Employee Count | 498 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.86 |
Taxes
| Income Tax | 50K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -51.92% in the last 52 weeks. The beta is 1.22, so RxSight's price volatility has been higher than the market average.
| Beta | 1.22 |
| 52-Week Price Change | -51.92% |
| 50-Day Moving Average | 32.52 |
| 200-Day Moving Average | 46.63 |
| Relative Strength Index (RSI) | 24.64 |
| Average Volume (20 Days) | 714.93K |
Income Statement
In the last 12 months, RxSight had revenue of 139.93M and earned -27.45M in profits. Earnings per share was -0.71.
| Revenue | 139.93M |
| Gross Profit | 98.94M |
| Operating Income | -36.86M |
| Net Income | -27.45M |
| EBITDA | -23.76M |
| EBIT | -36.86M |
| Earnings Per Share (EPS) | -0.71 |
Balance Sheet
The company has 16.71M in cash and 12.3M in debt, giving a net cash position of 4.41M.
| Cash & Cash Equivalents | 16.71M |
| Total Debt | 12.3M |
| Net Cash | 4.41M |
| Retained Earnings | -622.1M |
| Total Assets | 318.56M |
| Working Capital | 267.95M |
Cash Flow
In the last 12 months, operating cash flow was -16.95M and capital expenditures -5.44M, giving a free cash flow of -22.39M.
| Operating Cash Flow | -16.95M |
| Capital Expenditures | -5.44M |
| Free Cash Flow | -22.39M |
| FCF Per Share | -0.58 |
Margins
Gross margin is 70.71%, with operating and profit margins of -26.34% and -19.62%.
| Gross Margin | 70.71% |
| Operating Margin | -26.34% |
| Pretax Margin | -19.59% |
| Profit Margin | -19.62% |
| EBITDA Margin | -16.98% |
| EBIT Margin | -26.34% |
| FCF Margin | -16% |
Dividends & Yields
RXST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.63% |
| FCF Yield | -2.05% |
Analyst Forecast
The average price target for RXST is $47.5, which is 76.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $47.5 |
| Price Target Difference | 76.2% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 17.17 |
| Piotroski F-Score | 1 |